Reddit Posts
Top Earnings Trades For March 06 2023 - Two trades on the radar for today
OCUL very late day trading halt
IS $OCUL in a massive short squeeze - any reason?
Mentions
OCUL biotech company doing macular degeneration
I’m over 100% long term gains on TGTX. Large positions in ARQT, RARE, SWTX, OCUL and ASND. Speculative position in ATYR (up 20%) already.
Idk go look it up if he’s talked about them. But I personally trimmed 1/3 off my vktx and loaded more ARQT and OCUL today (still holding 2400 shares though)
I like eyeballs. I am having a blast with ALDX. Their dry eye disease drug Reproxalap and partnership with ABBV is good stuff. I also suggest looking into OCUL. I am currently just following Wet Age Macular Degeneration market... OTLK is trying...
!Banbot OCUL @11.75 8d
I’m buying calls on OCUL and puts on RYZB in regarded terms
Just did the Google’s: OCUL, RYZB, and FIX REPORT EARNINGS 3/4
My picks are biotech, OCUL, ARQT, GOSS, HROW, LRMR
GFAI, PPSI, OCUL so hot rn
Regarding OCUL and DKS, I suggest you carefully analyze their fundamentals and technical aspects to determine whether they are in line with your trading strategy and risk appetite. In addition, it is important to understand your trading objectives and risk management plan to ensure that you can maintain a stable trading strategy. Finally, please remember that the transaction involves risks, so please be careful and take appropriate risk control measures. Wish you a smooth transaction!
$SKYT, $RIOT, $LAC, and $OCUL saved my ass today, and so did the slow recovery of $RIVN (which is another bag I've been stuck holding for a month that I'm not happy about)...I've learned to not throw money at EV companies, even if you believe in their goals and tech, unless you're in it for the long haul...(I'm looking at you, AMV, you bastards)
Anyone know what's going on with OCUL?
anybody check out OCUL? I think this one is a real one that will pay very big
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: OCUL. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
Sell TDOC, TTCF, OCUL, MTTR. There you go.
Comstock Mining $**LODE** gold &/or lithium battery recycling Ocean Power Technologies $**OPTT** power from ocean waves Ocular Theraputix $**OCUL** fix eyes Viking Mines $**VKA**.AU ?? Gravitas Financial $**GFI**.V (ex SearchGold -- Central African Republic!) Sionix $**SINX** water treatment with bubbles "This one can't lose." Golden Share $**GSH.**TO ex ?? Aladdin Separation Tech. $**ASPT**.GRAY novel lixivient for gold
My last short term strategy consisted primarily of the biotech market. Stocks like $OCUL $NVAX $DVAX. They we're all dependent on their drug pipeline, every short term strategy is going to be different. Gotta find your own.
I wouldn’t view as holding on to the stock as a way of supporting the companies - the amount you hold is trivial and will have no impact to the stock price if you sell. In terms of management teams being professional and passionate, most are just looking out for their economic interests. BBIO: Essentially a west coast version of Roivant now. Management looks for me-too drugs to follow behind a recently established mechanism to try cashing in on its potential. The company’s most important and valuable drug (acquired from Eidos - originally a separate IPO management cashed in on) just horrifically failed a Phase 3 trial, which is why it fell so much in December. This company is a great example of the business model in biotech and is probably dead money. Some will try to speculate on the rest of the pipeline. OCUL: There was an opportunity to cash out at $20 a year ago. This company has been working on sustained release eye conditions and has seen a long, painful process. Hope they can actually get more clinical success in wet AMD, glaucoma, etc. Out of the 3 companies you listed, this probably has the highest potential to rebound. PRTA: This one has a weak pipeline and Alzheimer’s likely won’t look good. While it shot up on hype, it’s on its way down.
BridgeBio and Prothena are working on amyloidosis, which someone close to me is dealing with. $OCUL is just a classic stock tip from a friend which of course I'm down like 70% on lol.
Please, please let me know what you think of OCUL
$CLF going nuts after record earnings. ​ $OCUL drops out in 30 minutes
>$OCUL - Ocular Therapeutix(TM) Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2021-10-22 ^08:00:28 ^EDT-0400
>$OCUL Halted due to pending news ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2021-10-22 ^07:55:16 ^EDT-0400
$OCUL already up +15% today. FDA approval just announced should rocket. . More milestones coming.
OCUL not anything til the 18th that I could find CRVS nothing til November that I could find YMTX I haven't found anything that would be this week
$OCUL $YMTX $CRVS. (1ST two are 10 buck stocks).
haha, they are not penny stocks all PDUFA plays for October. Picked these up today: $CCXI, $AVDL, $OYST, $OCUL and $EYEN
I have a fairly modest (800-ish shares) position in [Ocular Therapeutix (OCUL)](https://finance.yahoo.com/quote/OCUL?p=OCUL) that I'm thinking about making significantly larger in the next few weeks. I'd welcome any thoughts on OCUL. * 7.50 - 24.30 is the 52-week range * 10.70 closing price yesterday * Current market cap, 818 million. * 24.43 PT, per Yahoo Finance * Raymond James (my broker) has analyst coverage and has a 25.00 PT on it, rated strong buy * Dextenza is their leading product, currently approved to treat pain and inflammation after eye surgery. * Upcoming catalyst: [10/18 - the PDUFA (Prescription Drug User Fee Act) date](https://www.biopharmcatalyst.com/calendars/pdufa-calendar) for Dextenza to, perhaps, be approved for treatment of chronic dry eyes. When the FDA accepts a new filing for the approval of a drug, the FDA must complete its review within 10-months. The PDUFA date is the end of the 10-month review period. * If the FDA approves Dextenza to treat dry eye, the price should run up hard. If there's no approval, its going to drop, but presumably not as much as if OCUL were seeking first time approval for ANY use.
Yeah didn’t expect to go up so much when I posted about it a month ago, having the same feeling on OCUL
Somebody smart take a look at Ocular Therapeutics (OCUL) chart and tell if it looks like it is on an upward trend.
Y’all should check out OCUL and NIO, NIO is having a earnings report tonight, and they are a lithium battery company! 👀
I have $DNLI on my watch list, but haven't bought in. I heard of it from my wife's co-workers that invest in bio quite a bit. $OCUL is what I'm looking at now due to the interesting therapeutic delivery it offers for eye issues (and my wife is in the eyeball field). I think the tech will expand to other specialties outside of ophthalmology.